These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 35782986

  • 41. Calcium ions promote primary renal epithelial cell differentiation into cells with bone-associated phenotypes via transforming growth factor-β1-induced epithelial-mesenchymal transition in idiopathic hypercalciuria patients.
    He D, Wang S, Jia Z, Cui L, Lu Y, Hu H, Qin B.
    Mol Med Rep; 2015 Mar; 11(3):2199-206. PubMed ID: 25394514
    [Abstract] [Full Text] [Related]

  • 42. 1,25-Dihydroxyvitamin D3 Controls a Cohort of Vitamin D Receptor Target Genes in the Proximal Intestine That Is Enriched for Calcium-regulating Components.
    Lee SM, Riley EM, Meyer MB, Benkusky NA, Plum LA, DeLuca HF, Pike JW.
    J Biol Chem; 2015 Jul 17; 290(29):18199-18215. PubMed ID: 26041780
    [Abstract] [Full Text] [Related]

  • 43. Vitamin D and type II sodium-dependent phosphate cotransporters.
    Kido S, Kaneko I, Tatsumi S, Segawa H, Miyamoto K.
    Contrib Nephrol; 2013 Jul 17; 180():86-97. PubMed ID: 23652552
    [Abstract] [Full Text] [Related]

  • 44. Vitamin D and calcium receptors: links to hypercalciuria.
    Bai S, Favus MJ.
    Curr Opin Nephrol Hypertens; 2006 Jul 17; 15(4):381-5. PubMed ID: 16775452
    [Abstract] [Full Text] [Related]

  • 45. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC, Quach HP, Vieth R, Pang KS.
    Am J Physiol Endocrinol Metab; 2013 May 01; 304(9):E977-89. PubMed ID: 23482451
    [Abstract] [Full Text] [Related]

  • 46. Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats.
    Bushinsky DA, Willett T, Asplin JR, Culbertson C, Che SP, Grynpas M.
    J Bone Miner Res; 2011 Aug 01; 26(8):1904-12. PubMed ID: 21351146
    [Abstract] [Full Text] [Related]

  • 47. Expression of vitamin D receptor, CYP27B1 and CYP24A1 hydroxylases and 1,25-dihydroxyvitamin D3 levels in stone formers.
    Melo TL, Esper PLG, Zambrano LI, Ormanji MS, Rodrigues FG, Heilberg IP.
    Urolithiasis; 2020 Feb 01; 48(1):19-26. PubMed ID: 31696245
    [Abstract] [Full Text] [Related]

  • 48. Mechanism of hypercalciuria in genetic hypercalciuric rats. Inherited defect in intestinal calcium transport.
    Bushinsky DA, Favus MJ.
    J Clin Invest; 1988 Nov 01; 82(5):1585-91. PubMed ID: 3183056
    [Abstract] [Full Text] [Related]

  • 49. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S, Shevde NK, Pike JW.
    J Bone Miner Res; 2005 Feb 01; 20(2):305-17. PubMed ID: 15647825
    [Abstract] [Full Text] [Related]

  • 50. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells.
    Meyer MB, Watanuki M, Kim S, Shevde NK, Pike JW.
    Mol Endocrinol; 2006 Jun 01; 20(6):1447-61. PubMed ID: 16574738
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Low Sodium Diet Decreases Stone Formation in Genetic Hypercalciuric Stone-Forming Rats.
    Krieger NS, Grynpas M, VandenEynde A, Asplin JR, Frick KK, Kim MH, Ramos FM, Granja I, Bushinsky DA.
    Nephron; 2019 Jun 01; 142(2):147-158. PubMed ID: 30726853
    [Abstract] [Full Text] [Related]

  • 57. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M, Freedman LP, Li H, Christakos S.
    Mol Endocrinol; 1998 Sep 01; 12(9):1367-79. PubMed ID: 9731705
    [Abstract] [Full Text] [Related]

  • 58. Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone-forming patients.
    Rendina D, Mossetti G, Viceconti R, Sorrentino M, Castaldo R, Manno G, Guadagno V, Strazzullo P, Nunziata V.
    Urology; 2004 Oct 01; 64(4):833-8. PubMed ID: 15491743
    [Abstract] [Full Text] [Related]

  • 59. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.
    J Endocrinol; 1997 Sep 01; 154 Suppl():S57-73. PubMed ID: 9379138
    [Abstract] [Full Text] [Related]

  • 60. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
    Brown AJ, Zhong M, Finch J, Ritter C, Slatopolsky E.
    Endocrinology; 1995 Apr 01; 136(4):1419-25. PubMed ID: 7895652
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.